1 line
3.1 KiB
JSON
1 line
3.1 KiB
JSON
{"adrenal insufficiency": 9.11, "alveolar proteinosis": 140.2, "anti-cyclic citrullinated peptide antibody positive": 12.09, "antibody test positive": 49.09, "apparent death": 1085.22, "arthritis": 4.19, "arthrodesis": 202.51, "arthropathy": 19.7, "autoinflammatory disease": 212.79, "back disorder": 9.69, "blood pressure fluctuation": 5.56, "body height below normal": 551.4, "bone density decreased": 2.41, "c-reactive protein abnormal": 62.57, "c-reactive protein increased": 12.84, "cataract": 2.08, "clubbing": 200.45, "condition aggravated": 4.91, "contraindicated product administered": 45.57, "deep vein thrombosis": 5.39, "deformity": 108.68, "diverticulitis": 35.71, "drug hypersensitivity": 14.11, "drug ineffective": 6.62, "drug ineffective for unapproved indication": 6.42, "drug intolerance": 17.24, "drug reaction with eosinophilia and systemic symptoms": 6.2, "drug specific antibody": 67.26, "endodontic procedure": 124.58, "foot deformity": 12.78, "glucose tolerance impaired": 17.92, "haemophagocytic lymphohistiocytosis": 34.13, "hand deformity": 14.29, "heart rate decreased": 4.9, "hepatotoxicity": 11.19, "human antichimeric antibody positive": 577.11, "ill-defined disorder": 21.23, "impaired healing": 7.88, "infection": 3.13, "inflammation": 2.46, "infusion related reaction": 2.64, "injection site hypersensitivity": 15.5, "injection site reaction": 2.01, "intentional product use issue": 8.06, "interstitial lung disease": 4.5, "intestinal sepsis": 577.15, "joint arthroplasty": 159.33, "joint injury": 12.07, "joint swelling": 16.58, "juvenile idiopathic arthritis": 92.83, "knee arthroplasty": 31.13, "liver function test abnormal": 2.3, "localised infection": 8.33, "loss of consciousness": 2.65, "loss of personal independence in daily activities": 2.42, "lung disorder": 2.58, "medication error": 4.57, "mobility decreased": 11.23, "mouth ulceration": 2.94, "multiple-drug resistance": 32.77, "musculoskeletal disorder": 20.77, "musculoskeletal pain": 5.98, "no adverse event": 6.73, "nodule": 10.45, "obesity": 16.23, "off label use": 4.25, "osteoarthritis": 3.56, "pain": 2.33, "photosensitivity reaction": 8.8, "polyarteritis nodosa": 160.82, "polyarthritis": 12.95, "prescribed underdose": 5.68, "product use in unapproved indication": 3.35, "product use issue": 2.28, "psoriasis": 2.53, "pulmonary embolism": 4.05, "pulmonary fibrosis": 5.39, "pulmonary thrombosis": 38.29, "quality of life decreased": 12.99, "red blood cell sedimentation rate abnormal": 165.24, "red blood cell sedimentation rate increased": 60.18, "renal failure": 3.68, "rheumatoid arthritis": 16.68, "rheumatoid factor positive": 40.28, "sepsis": 3.95, "septic shock": 5.22, "serum ferritin increased": 15.38, "shoulder arthroplasty": 85.18, "skin fissures": 15.76, "smear cervix abnormal": 92.49, "still's disease": 68.91, "stomatitis": 2.34, "synovitis": 24.58, "terminal state": 50.56, "therapeutic product effect decreased": 17.77, "therapeutic product effect incomplete": 10.31, "therapeutic response decreased": 3.64, "therapy non-responder": 8.36, "thrombosis": 2.58, "tooth disorder": 9.8, "toothache": 5.63, "toxicity to various agents": 2.14, "treatment failure": 16.39} |